 AC Immune SA NASDAQ: ACIU has gained a multi-million investment from the principal backers of BioNTech SE NASDAQ: BNTX while acquiring a possible Parkinsons disease vaccine. It announced a 25 million private share placement with a group of investors led by Athos Service GmbH. 